Green-light | Jotup

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMBK, AAIC, GRNA

Retrieved on:

Thursday, June 1, 2023

Arlington Asset Investment, Intuition, PBC, Green-light, Sale, Acquisition, Advertising, Fraud, NYSE, Security (finance)

If you are an Embark shareholder, click here to learn more about your rights and options .

Key Points:

If you are an Embark shareholder, click here to learn more about your rights and options .
If you are an Arlington Asset shareholder, click here to learn more about your rights and options .
Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

GREENLIGHT BIOSCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GreenLight Biosciences Holdings, PBC - GRNA

Retrieved on:

Thursday, June 1, 2023

Class Action Lawsuit, Professional Services, Legal, GRNA, Green-light, KSF, PBC, Sale

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of GreenLight Biosciences Holdings, PBC (NasdaqGM: GRNA) to a consortium led by Fall Line Capital, LLC.

Key Points:

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of GreenLight Biosciences Holdings, PBC (NasdaqGM: GRNA) to a consortium led by Fall Line Capital, LLC.
Under the terms of the proposed transaction, shareholders of GreenLight will receive $0.30 in cash for each share of GreenLight that they own.
Please note that the merger is structured as a tender offer, such that time may be of the essence.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Greenlight Guru Modernizes Validation Approach to Streamline Software Implementation and Adoption for Medical Device Companies

Retrieved on:

Thursday, June 1, 2023

Benchmark, Validation, QMS, CSA, ISO, Risk management, LexisNexis Risk Solutions, Green-light, Production, CSV, Patient, Heel, FDA, Medtech, Software, Medical device

INDIANAPOLIS, June 1, 2023 /PRNewswire-PRWeb/ -- Greenlight Guru, the leading provider of cloud-based software for MedTech companies, today announced that it is adopting an automated, risk-based approach to software validation and strategically updating its Software Validation Package for customers. The modernized approach is in line with FDA guidance on Computer Software Assurance (CSA) and requirements of ISO 13485:2016 to ease the burden of validating new software for MedTech companies.

Key Points:

The risk-based approach to software validation will help customers efficiently and effectively assure compliance when implementing Greenlight Guru software.
INDIANAPOLIS, June 1, 2023 /PRNewswire-PRWeb/ -- Greenlight Guru, the leading provider of cloud-based software for MedTech companies, today announced that it is adopting an automated, risk-based approach to software validation and strategically updating its Software Validation Package for customers.
In 2022, FDA released a draft guidance, Computer Software Assurance for Production and Quality System Software, as part of a greater, industry-wide shift toward a more balanced approach to software validation for MedTech companies.
"The shift from CSV to CSA is a move toward a more balanced, risk-based approach to software validation," says Brian Gaffney, CTO of Greenlight Guru.

GRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GreenLight Biosciences Holdings, PBC Is Fair to Shareholders

Retrieved on:

Tuesday, May 30, 2023

Class Action Lawsuit, Professional Services, Legal, GRNA, Green-light, Fraud, Fall line, Advertising, PBC, Sale, Security (finance)

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) to a group of buyers led by Fall Line Capital, LLC for $0.30 per share is fair to GreenLight shareholders.

Key Points:

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) to a group of buyers led by Fall Line Capital, LLC for $0.30 per share is fair to GreenLight shareholders.
On behalf of GreenLight shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Follett Higher Education and GreenLight Credentials Partner to Support Postsecondary Equity and Attainment

Retrieved on:

Wednesday, May 17, 2023

University, Green-light, K-12, School, Follett, Student, Partnership, Education, Nursing, Management

WESTCHESTER, Ill., May 17, 2023 /PRNewswire/ -- Follett Higher Education , North America's largest campus retailer, today announced a strategic partnership with GreenLight Credentials , the premier verified educational credentials blockchain platform.

Key Points:

WESTCHESTER, Ill., May 17, 2023 /PRNewswire/ -- Follett Higher Education , North America's largest campus retailer, today announced a strategic partnership with GreenLight Credentials , the premier verified educational credentials blockchain platform.
"Our exclusive partnership with GreenLight Credentials will further Follett's work to support more equity and affordability in higher education, thereby increasing recruitment, retention, and completion," said Ryan Petersen, President of Follett Higher Education.
Follett Higher Education is now a minority equity holder of GreenLight Credentials and the platform's exclusive higher education retail partner.
Follett and GreenLight Credentials will also endeavor to make the platform free-of-charge to the K-12 districts that drive enrollment to Follett higher education institutions that elect to utilize the GreenLight Credentials platform.

NEA Appoints Technology Investors Aaron Jacobson and Vanessa Larco to Senior Investing Team Roles; Lily Huang, Danielle Lay and Luke Pappas Promoted to Partner

Retrieved on:

Tuesday, May 16, 2023

Aaron Jacobson and Vanessa Larco , both technology investors, have been elevated to senior investing team roles with appointments to the firm's Venture Capital Investment Committee.

Key Points:

Aaron Jacobson and Vanessa Larco , both technology investors, have been elevated to senior investing team roles with appointments to the firm's Venture Capital Investment Committee.
NEA also promoted three individuals to Partner: Danielle Lay and Luke Pappas on the technology investing team, and healthcare investor Lily Huang .
Aaron Jacobson , who joined NEA in 2011, is an enterprise technology investor focused on AI/ML, developer tools, cloud infrastructure, robotics, and cybersecurity.
On the technology team, Alex Sharata was named Principal and Arjun Jain , Mustafa Neemuchwala , and Hunter Worland were promoted to Senior Associate.

GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress

Retrieved on:

Thursday, May 11, 2023

Autumn, Sustainability reporting, PBC, Farmer, Agriculture, Green-light, Research, RNA, GRNA, Public expenditure, EPA, Sustainability, Health, D, Pharmaceutical industry

BOSTON, May 11, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences, PBC (Nasdaq: GRNA), a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, today reported operational highlights and financial results for the first quarter ended March 31, 2023.

Key Points:

BOSTON, May 11, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences, PBC (Nasdaq: GRNA), a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, today reported operational highlights and financial results for the first quarter ended March 31, 2023.
“Following regulatory submission of our Varroa mite honeybee solution in the first quarter, we now have two products under EPA review.
Collaboration Revenue: Collaboration revenue was $3.8 million during the first quarter of 2023, compared to no collaboration revenue during the first quarter of 2022.
Net Loss: The Company’s net loss was $28.5 million for the first quarter of 2023, compared to $38.2 million during the first quarter of 2022.

United Community Partners with Greenlight to Help Families Raise Financially-Smart Kids and Teens

Retrieved on:

Tuesday, April 25, 2023

Financial Literacy Month, Parent, Business, Partnership, Community, SVP, Tutoring, United Community, United, Green-light

GREENVILLE, S.C., April 25, 2023 /PRNewswire/ -- United Community is proud to announce a new partnership with Greenlight® Financial Technology, Inc. to provide United customers free access to the award-winning Greenlight family finance app, available through the Greenlight for Banks program.

Key Points:

GREENVILLE, S.C., April 25, 2023 /PRNewswire/ -- United Community is proud to announce a new partnership with Greenlight® Financial Technology, Inc. to provide United customers free access to the award-winning Greenlight family finance app, available through the Greenlight for Banks program.
"United's partnership with Greenlight will further enable our customers to teach their children about money, helping form healthy financial habits that will last a lifetime," said Lynn Harton, Chairman and CEO of United Community.
Kids and teens also have access to Greenlight Level Up™ , an in-app financial literacy game with best-in-class curriculum, educational challenges, and rewards.
"Community banks like United Community are uniquely well-equipped to help improve financial literacy with their strong commitment to the community and excellent care of customers."

Greenlight Guru Builds Strong Momentum in Q1 2023 as Medical Device Companies Move to Modern Digital Solutions

Retrieved on:

Wednesday, April 19, 2023

INDIANAPOLIS, April 19, 2023 /PRNewswire-PRWeb/ -- Greenlight Guru, the leading provider of cloud-based solutions for MedTech companies, announced a record-breaking quarter today. As the demand for modern digital solutions continues to increase in the medical device industry, Greenlight Guru has experienced 145% growth over the past 24 months.

Key Points:

INDIANAPOLIS, April 19, 2023 /PRNewswire-PRWeb/ -- Greenlight Guru, the leading provider of cloud-based solutions for MedTech companies, announced a record-breaking quarter today.
As the demand for modern digital solutions continues to increase in the medical device industry, Greenlight Guru has experienced 145% growth over the past 24 months.
Greenlight Guru helps MedTech companies improve speed and efficiency by providing user-friendly and fully traceable software solutions for their quality management and clinical data needs.
Additionally, Greenlight Guru recently announced its expanded Partner Program , which helps connect medical device companies with a vast ecosystem of MedTech consultants, advisors, and more.

GreenLight Biosciences Releases Inaugural Sustainability Report

Retrieved on:

Wednesday, April 12, 2023

Drug development, Sustainability reporting, Farmer, Agriculture, Crop protection, Green-light, Global health, RNA, GRNA, Plant, Biodiversity, Climate, Health, Food security, Environment, Chief sustainability officer, Pharmaceutical industry

BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today released its inaugural Sustainability Report .

Key Points:

BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today released its inaugural Sustainability Report .
The report contains the company's sustainability roadmap and includes sustainability updates on its business areas—from developing new tools for farmers that are designed to be targeted, effective, and environmentally responsible to vaccine candidates and potential therapies to improve global health outcomes.
The report highlights seven agriculture products that could reach the market by 2026, subject to applicable regulatory approvals, and three drug development candidates in the human health portfolio.
GreenLight will regularly assess the quality of its sustainability data, focusing on continuous improvements and meeting the expectations of its stakeholders.